Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RISPERIDONE Cause Obsessive-compulsive disorder? 292 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 292 reports of Obsessive-compulsive disorder have been filed in association with RISPERIDONE (Risperidone). This represents 0.4% of all adverse event reports for RISPERIDONE.

292
Reports of Obsessive-compulsive disorder with RISPERIDONE
0.4%
of all RISPERIDONE reports
5
Deaths
219
Hospitalizations

How Dangerous Is Obsessive-compulsive disorder From RISPERIDONE?

Of the 292 reports, 5 (1.7%) resulted in death, 219 (75.0%) required hospitalization, and 21 (7.2%) were considered life-threatening.

Is Obsessive-compulsive disorder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RISPERIDONE. However, 292 reports have been filed with the FAERS database.

What Other Side Effects Does RISPERIDONE Cause?

Gynaecomastia (24,453) Off label use (10,376) Abnormal weight gain (9,418) Weight increased (6,885) Emotional disorder (5,809) Product use in unapproved indication (5,551) Drug ineffective (5,232) Injury (4,447) Hyperprolactinaemia (4,124) Galactorrhoea (3,513)

What Other Drugs Cause Obsessive-compulsive disorder?

ARIPIPRAZOLE (1,675) QUETIAPINE (368) CLOZAPINE (345) OLANZAPINE (337) MONTELUKAST (314) FLUOXETINE (269) LITHIUM (238) LAMOTRIGINE (198) CLOMIPRAMINE (187) GABAPENTIN (185)

Which RISPERIDONE Alternatives Have Lower Obsessive-compulsive disorder Risk?

RISPERIDONE vs RITALIN RISPERIDONE vs RITLECITINIB RISPERIDONE vs RITODRINE RISPERIDONE vs RITONAVIR RISPERIDONE vs RITUXAN

Related Pages

RISPERIDONE Full Profile All Obsessive-compulsive disorder Reports All Drugs Causing Obsessive-compulsive disorder RISPERIDONE Demographics